Le Lézard
Classified in: Health
Subjects: CCA, FVT

Jazz Pharmaceuticals Announces Webcast Discussion of Data to be Presented at APSS


DUBLIN, May 24, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast to discuss data to be presented on solriamfetol (JZP-110) and Xyrem® (sodium oxybate) oral solution at the Annual Meeting of the Associated Professional Sleep Societies (APSS) in Baltimore, MD from June 3-6, 2018.

The live webcast will begin at 7:00 p.m. EDT on June 5, 2018.  Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. 

Audio webcast/conference call:
U.S. dial-in number:  +1 800 239 9838
International dial-in numbers: click here
Passcode: 5629915

An audio archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at http://www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs.  The company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.  In these areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Defitelio® (defibrotide sodium) and Vyxeos® (daunorubicin and cytarabine) liposome for injection in the U.S. and markets Erwinase® and Defitelio® (defibrotide) in countries outside the U.S.  For country-specific product information, please visit http://www.jazzpharmaceuticals.com/products.  For more information, please visit http://www.jazzpharmaceuticals.com/ and follow us on Twitter at @JazzPharma.

Jazz Pharmaceuticals Logo (PRNewsFoto/Jazz Pharmaceuticals plc) (PRNewsFoto/Jazz Pharmaceuticals plc)

 

SOURCE Jazz Pharmaceuticals plc


These press releases may also interest you

at 10:00
Iris Wellness Group Launches Outpatient Drug and Alcohol Detox Program in Chattanooga, TN
Iris Wellness Group has introduced an Outpatient Drug and Alcohol Detox Program in Chattanooga, TN, offering personalized care for individuals grappling with addiction. Launched on April 15th, 2024, this unique detox program allows patients to...

at 10:00
CREO's Mike Townley Receives Triangle Business Journal's 2024 Life Sciences Award
CREO Inc., the preferred consultancy to the world's most promising companies that seek to improve human health, today announced that Mike Townley, President and Co-Founder, has been honored with...

at 10:00
PatientRightsAdvocate.org files Amicus Brief in U.S. Department of Labor Case Against Blue Cross and Blue Shield of Minnesota
PatientRightsAdvocate.org filed an amicus brief in the case of Secretary Julie A. Su, Acting Secretary of Labor v. Blue Cross and Blue Shield (BCBS) of Minnesota, arguing that their motion to dismiss the case should be denied on the basis that BCBS...

at 09:38
Nonprofits from Inception Fertility and Caden Lane Team Up to Expand Financial Accessibility to Fertility Care
The Wyatt Foundation and The Conceive Fertility Foundation announce today a joint partnership that will award $15,000 grants to five individuals/couples who need in vitro fertility (IVF) to build their families. Launching during National Infertility...

at 09:38
Commons Clinic Invests $9.75M in Advanced Spine Surgery Center; Launches Next-Gen Ambulatory Surgical Platform "Theater"
New platform and surgery center investment adds advanced facility capabilities to specialty care network, strengthening in-person treatment and attracting leading orthopedic surgeons and physiciansWith Theater launch, value-based MSK care visionary...

at 09:34
Bulletin from annual general meeting in Medicover AB (publ)
The below resolutions were passed at Medicover's annual general meeting (the "AGM") held today on 26 April 2024. Election of the board of directors and auditor The AGM resolved, in accordance with the proposal from the nomination committee, that the...

More news about Health...


News published on and distributed by: